|
Volumn 318, Issue 12, 2017, Pages 1095-1097
|
Going with the flow: The promise and challenge of liquid biopsies
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
DNA;
BLOOD SAMPLING;
CANCER CELL;
CANCER DIAGNOSIS;
CANCER PROGNOSIS;
CANCER SURVIVAL;
CELL COUNT;
CIRCULATING TUMOR CELL;
DIAGNOSTIC ACCURACY;
EARLY CANCER;
EXON;
GENE MUTATION;
HUMAN;
LIQUID BIOPSY;
METASTASIS;
MINIMAL RESIDUAL DISEASE;
NON SMALL CELL LUNG CANCER;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
SHORT SURVEY;
SOLID MALIGNANT NEOPLASM;
TUMOR GROWTH;
TUMOR LOCALIZATION;
VALIDITY;
BIOPSY;
BLOOD;
MUTATION;
NEOPLASMS;
PROCEDURES;
PROGNOSIS;
TUMOR EMBOLISM;
BIOMARKERS, TUMOR;
BIOPSY;
DNA, NEOPLASM;
HUMANS;
MUTATION;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOPLASTIC CELLS, CIRCULATING;
PROGNOSIS;
|
EID: 85029920162
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2017.10203 Document Type: Short Survey |
Times cited : (20)
|
References (0)
|